Ess Cee Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 4.49 M
as on 24-10-2024
- Company Age 38 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 13.62%
(FY 2023)
- Profit -5.49%
(FY 2023)
- Ebitda -4.48%
(FY 2023)
- Net Worth 34.01%
(FY 2023)
- Total Assets 18.41%
(FY 2023)
About Ess Cee Biotech (India)
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 4.49 M, as per Ministry of Corporate Affairs (MCA) records.
Suresh Srivastava, Sunita Srivastava, and Sanjay Tyagi serve as directors at the Company.
- CIN/LLPIN
U74210UP1986PTC007900
- Company No.
007900
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 May 1986
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ess Cee Biotech (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Srivastava  | Director | 13-May-1986 | Current |
| Sunita Srivastava | Director | 13-May-1986 | Current |
| Sanjay Tyagi | Additional Director | 15-Oct-2024 | Current |
Financial Performance of Ess Cee Biotech (India).
Ess Cee Biotech (India) Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.62% increase. The company also saw a slight decrease in profitability, with a 5.49% decrease in profit. The company's net worth Soared by an impressive increase of 34.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ess Cee Biotech (India)?
In 2023, Ess Cee Biotech (India) had a promoter holding of 94.26% and a public holding of 5.74%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chem Genes India Private LimitedActive 22 years 5 monthsSuresh Srivastava and Sunita Srivastava are mutual person
Magadh Avadh Chemical Industries Private LimitedActive 32 years 3 monthsSuresh Srivastava is a mutual person
- Milan Shyam Bio Sciences Private LimitedActive 5 years 2 months
Suresh Srivastava and Sunita Srivastava are mutual person
- Argosy Overseas Private LimitedActive 35 years 5 months
Suresh Srivastava and Sunita Srivastava are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ess Cee Biotech (India)?
Ess Cee Biotech (India) has a workforce of 101 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ess Cee Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ess Cee Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
